Pharmaceutical Impurity Testing Service refers to the analytical testing of pharmaceutical compounds to identify and quantify impurities or degradation products that may be present in drug substances or drug products. These impurities can arise from different sources such as drug manufacturing processes, storage conditions, or interactions with other chemical moieties. It is crucial to detect and monitor these impurities to ensure the safety, efficacy, and quality of pharmaceutical products, as some of them can cause adverse effects on human health. The testing process usually involves sophisticated analytical techniques such as chromatography, mass spectrometry, or spectroscopy, and must comply with regulatory requirements set by health authorities such as the FDA or EMA.
The global market for Pharmaceutical lmpurity Testing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Pharmaceutical lmpurity Testing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharmaceutical lmpurity Testing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pharmaceutical lmpurity Testing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pharmaceutical lmpurity Testing Service include Charles River, Intertek, Profacgen, Eurofins Analytical Science Laboratories, Inc. (E-ASL), SGS, Element, Drug Development Solutions Limited, Leeder Analytical and Thermo Fisher Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical lmpurity Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical lmpurity Testing Service by region & country, by Type, and by Application.
The Pharmaceutical lmpurity Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical lmpurity Testing Service.
麻豆原创 Segmentation
By Company
Charles River
Intertek
Profacgen
Eurofins Analytical Science Laboratories, Inc. (E-ASL)
SGS
Element
Drug Development Solutions Limited
Leeder Analytical
Thermo Fisher Scientific
Selvita
Impact Analytical
EKG Life Science Solutions, LLC (EKG Labs)
Merck
SwRI
Emery Pharma
Cotecna
Roche
Segment by Type:
Destructive Testing
Non-destructive Testing
Segment by Application
Biopharma
New Drug Research & Development
Gene Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical lmpurity Testing Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical lmpurity Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical lmpurity Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Pharmaceutical lmpurity Testing Service Product Introduction
1.2 Global Pharmaceutical lmpurity Testing Service 麻豆原创 Size Forecast
1.3 Pharmaceutical lmpurity Testing Service 麻豆原创 Trends & Drivers
1.3.1 Pharmaceutical lmpurity Testing Service Industry Trends
1.3.2 Pharmaceutical lmpurity Testing Service 麻豆原创 Drivers & Opportunity
1.3.3 Pharmaceutical lmpurity Testing Service 麻豆原创 Challenges
1.3.4 Pharmaceutical lmpurity Testing Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical lmpurity Testing Service Players Revenue Ranking (2023)
2.2 Global Pharmaceutical lmpurity Testing Service Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical lmpurity Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical lmpurity Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical lmpurity Testing Service
2.6 Pharmaceutical lmpurity Testing Service 麻豆原创 Competitive Analysis
2.6.1 Pharmaceutical lmpurity Testing Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical lmpurity Testing Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical lmpurity Testing Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Destructive Testing
3.1.2 Non-destructive Testing
3.2 Global Pharmaceutical lmpurity Testing Service Sales Value by Type
3.2.1 Global Pharmaceutical lmpurity Testing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical lmpurity Testing Service Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical lmpurity Testing Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharma
4.1.2 New Drug Research & Development
4.1.3 Gene Therapy
4.1.4 Others
4.2 Global Pharmaceutical lmpurity Testing Service Sales Value by Application
4.2.1 Global Pharmaceutical lmpurity Testing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical lmpurity Testing Service Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical lmpurity Testing Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical lmpurity Testing Service Sales Value by Region
5.1.1 Global Pharmaceutical lmpurity Testing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical lmpurity Testing Service Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical lmpurity Testing Service Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical lmpurity Testing Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
5.2.2 North America Pharmaceutical lmpurity Testing Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical lmpurity Testing Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical lmpurity Testing Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
5.5.2 South America Pharmaceutical lmpurity Testing Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical lmpurity Testing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical lmpurity Testing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical lmpurity Testing Service Sales Value
6.3 United States
6.3.1 United States Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.3.2 United States Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.5.2 China Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical lmpurity Testing Service Sales Value, 2019-2030
6.9.2 India Pharmaceutical lmpurity Testing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical lmpurity Testing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River
7.1.1 Charles River Profile
7.1.2 Charles River Main Business
7.1.3 Charles River Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.1.4 Charles River Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.1.5 Charles River Recent Developments
7.2 Intertek
7.2.1 Intertek Profile
7.2.2 Intertek Main Business
7.2.3 Intertek Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.2.4 Intertek Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.2.5 Intertek Recent Developments
7.3 Profacgen
7.3.1 Profacgen Profile
7.3.2 Profacgen Main Business
7.3.3 Profacgen Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.3.4 Profacgen Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.3.5 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Recent Developments
7.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL)
7.4.1 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Profile
7.4.2 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Main Business
7.4.3 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.4.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.4.5 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Recent Developments
7.5 SGS
7.5.1 SGS Profile
7.5.2 SGS Main Business
7.5.3 SGS Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.5.4 SGS Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.5.5 SGS Recent Developments
7.6 Element
7.6.1 Element Profile
7.6.2 Element Main Business
7.6.3 Element Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.6.4 Element Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.6.5 Element Recent Developments
7.7 Drug Development Solutions Limited
7.7.1 Drug Development Solutions Limited Profile
7.7.2 Drug Development Solutions Limited Main Business
7.7.3 Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.7.4 Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.7.5 Drug Development Solutions Limited Recent Developments
7.8 Leeder Analytical
7.8.1 Leeder Analytical Profile
7.8.2 Leeder Analytical Main Business
7.8.3 Leeder Analytical Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.8.4 Leeder Analytical Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.8.5 Leeder Analytical Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Selvita
7.10.1 Selvita Profile
7.10.2 Selvita Main Business
7.10.3 Selvita Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.10.4 Selvita Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.10.5 Selvita Recent Developments
7.11 Impact Analytical
7.11.1 Impact Analytical Profile
7.11.2 Impact Analytical Main Business
7.11.3 Impact Analytical Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.11.4 Impact Analytical Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.11.5 Impact Analytical Recent Developments
7.12 EKG Life Science Solutions, LLC (EKG Labs)
7.12.1 EKG Life Science Solutions, LLC (EKG Labs) Profile
7.12.2 EKG Life Science Solutions, LLC (EKG Labs) Main Business
7.12.3 EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.12.4 EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.12.5 EKG Life Science Solutions, LLC (EKG Labs) Recent Developments
7.13 Merck
7.13.1 Merck Profile
7.13.2 Merck Main Business
7.13.3 Merck Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.13.4 Merck Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.13.5 Merck Recent Developments
7.14 SwRI
7.14.1 SwRI Profile
7.14.2 SwRI Main Business
7.14.3 SwRI Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.14.4 SwRI Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.14.5 SwRI Recent Developments
7.15 Emery Pharma
7.15.1 Emery Pharma Profile
7.15.2 Emery Pharma Main Business
7.15.3 Emery Pharma Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.15.4 Emery Pharma Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.15.5 Emery Pharma Recent Developments
7.16 Cotecna
7.16.1 Cotecna Profile
7.16.2 Cotecna Main Business
7.16.3 Cotecna Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.16.4 Cotecna Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.16.5 Cotecna Recent Developments
7.17 Roche
7.17.1 Roche Profile
7.17.2 Roche Main Business
7.17.3 Roche Pharmaceutical lmpurity Testing Service Products, Services and Solutions
7.17.4 Roche Pharmaceutical lmpurity Testing Service Revenue (US$ Million) & (2019-2024)
7.17.5 Roche Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical lmpurity Testing Service Industrial Chain
8.2 Pharmaceutical lmpurity Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical lmpurity Testing Service Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical lmpurity Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Charles River
Intertek
Profacgen
Eurofins Analytical Science Laboratories, Inc. (E-ASL)
SGS
Element
Drug Development Solutions Limited
Leeder Analytical
Thermo Fisher Scientific
Selvita
Impact Analytical
EKG Life Science Solutions, LLC (EKG Labs)
Merck
SwRI
Emery Pharma
Cotecna
Roche
听
听
*If Applicable.
